Il Tolvaptan (OTSUKA) può essere un farmaco utile per i pazienti con ADPKD? Come Potrebbe Cambiare Il Trattamento Futuro Dei Pazienti Con Adpkd?

F. Scolari

doi:10.33393/gcnd.2012.1181

Can Tolvaptan (OTSUKA) be a useful drug for patients with ADPKD? How could future treatment of patients change with Adpkd?

Authors

F. Scolari Direttore II U.O. di Nefrologia e Dialisi, P.O. Montichiari A.O. Spedali Civili Brescia, Cattedra di Nefrologia Università di Brescia Presidente Comitato Scientifico AIRP onlus

DOI:

https://doi.org/10.33393/gcnd.2012.1181

Abstract

No abstract

Downloads

Download data is not yet available.

Downloads

PDF (Italiano)

Published

2018-01-26

How to Cite

Scolari, F. (2018). Can Tolvaptan (OTSUKA) be a useful drug for patients with ADPKD? How could future treatment of patients change with Adpkd?. Giornale Di Clinica Nefrologica E Dialisi, 24(4), 89–91. https://doi.org/10.33393/gcnd.2012.1181

Download Citation

Issue

Vol. 24 No. 4 (2012): October-December 2012

Section

Polycystic kidney disease - In collaboration with AIRP

License

Authors contributing to Giornale di Clinica Nefrologica e Dialisi (GCND) agree to publish their articles under the CC-BY-NC 4.0 license, which allows third parties to re-use the work without permission as long as the work is properly referenced and the use is non-commercial.